Could a new scan reveal hidden clues in breast cancer?
NCT ID NCT02284919
First seen Jan 11, 2026 · Last updated Jun 14, 2026 · Updated 16 times
Summary
This study tests a new type of PET/CT scan that uses a special tracer called [18F]ISO-1 to look at sigma-2 receptor activity in breast cancer tumors. About 30 adults with known or suspected breast cancer will receive the tracer and then have a PET/CT scan. The goal is to see if this imaging method can measure how fast cancer cells are growing, which might help doctors better understand the disease without needing a biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.